Two rules for the same blood test
Codes like Z13.6 are the reason written on the order; five-digit codes like 80061 name the test.
| Screening (42 CFR 410.17) | Diagnostic (NCD 190.23) | |
|---|---|---|
| Who | No apparent signs or symptoms of heart or blood vessel disease | A covered condition, or treatment that needs monitoring |
| How often | Once in 60 months (none paid in the 59 months after the month of the last one) | Yearly panel on long-term treatment or with borderline-high cholesterol; one part up to six times in year one; total or LDL cholesterol three times a year once goals are met |
| Tests that count | Lipid panel (80061) or total cholesterol, HDL and triglycerides (82465, 83718, 84478) | Those, plus a measured LDL (83721) and the advanced lipoprotein tests on the rule's code list (83700, 83701, 83704) |
| Reason on the order | The screening code Z13.6 | The condition, such as hyperlipidemia (E78.5) or type 2 diabetes (E11.9) |
| What you pay (Original Medicare) | $0 if the provider accepts assignment | Usually $0 for a covered diagnostic lab test |
| What Medicare pays the lab | $13.39 for the panel; $18.28 if the three parts are billed one by one (our sum) | Same rates |
Count months, not years
The regulation's wording is "has not had the screening tests paid for by Medicare during the preceding 59 months following the month in which the last cardiovascular screening tests were performed." CMS's claims manual calls the same limit "once every 60 months." Read together, the count starts with the month after your last screening, and you become eligible in the same calendar month five years later. That is our reading of the rule, and it matches the way CMS's manual counts its other monthly screening limits.
| Last screening panel paid by Medicare | First date a screening panel is paid again |
|---|---|
| March 22, 2022 | March 1, 2027 |
| November 30, 2021 | November 1, 2026 |
In our reading, two things reset nothing: a diagnostic panel in between does not restart the screening clock, because the limit counts screening tests only, and a change of lab does not either, because the rule counts tests Medicare paid for, wherever they were done.
When the panel stops being screening
NCD 190.23 lists who can have lipid testing as a diagnostic test: people with heart or artery disease, primary or secondary lipid disorders (it names diabetes, gut absorption problems and chronic kidney failure), and diseases that change how the body handles fat, among them nephrotic syndrome, pancreatitis, liver disease and an under- or overactive thyroid. In the rule's October 2026 code list, high blood pressure (I10), obesity (E66.9), fatty liver (K76.0), stage 3 kidney disease and hypothyroidism are all covered diagnoses for the panel.
What does not move you out of the screening group is risk alone. The rule says: "Lipid testing in asymptomatic individuals is considered to be screening regardless of the presence of other risk factors such as family history, tobacco use, etc." Its October 2026 code list matches for the common cases: a family history of heart disease (Z82.49) and tobacco use (Z72.0) are not on it. Two narrower family histories are on it, with no restriction to particular tests: a family history of familial hypercholesterolemia (Z83.42) and of elevated lipoprotein(a) (Z83.430). If heart disease runs in your family and you have no other condition, the 5-year screening limit is the one that applies, and a yearly panel is likely to be denied; if a parent, brother or sister has familial hypercholesterolemia, tell the clinician, because that history is a coded reason.
How often once you are treated
- Starting treatment: "Any one component of the panel or a measured LDL may be reasonable and necessary up to six times the first year for monitoring dietary or pharmacologic therapy."
- On long-term treatment, or borderline-high cholesterol: a full panel once a year "will usually be adequate," with a total cholesterol or measured LDL for visits in between if triglycerides are not high.
- At goal: total or LDL cholesterol "may be measured three times yearly after treatment goals have been achieved."
- Marked elevations or a treatment change that is not working can justify more frequent tests.
- No treatment advised: "If no dietary or pharmacological therapy is advised, monitoring is not necessary."
- Unexplained liver test changes: a lipid panel "would generally not be indicated more than twice per year."
- Advanced lipoprotein tests (codes 83700, 83701, 83704): "Electrophoretic or other quantitation of lipoproteins may be indicated if the patient has a primary disorder of lipoid metabolism."
For what your numbers mean at each age, see our guide to cholesterol levels by age.
What triggers a bill
A screening panel billed before the 60th month is rejected, and CMS's claims manual tells contractors to print the Medicare Summary Notice message "Medicare does not pay for this many services or supplies." Because this is a frequency limit, CMS lets labs hand out an Advance Beneficiary Notice routinely for it. If you sign that notice and choose to have the test, the lab may charge its usual fee, which CMS says "is not limited to the Medicare fee schedule." If a required notice was not given properly, you are generally not liable, under chapter 30 of CMS's claims manual. Our page on what a Medicare ABN for a lab test means covers the three options on the form.
A screening order also cannot carry extra tests. The screening code Z13.6 is covered only with the panel and its three parts, so an advanced lipoprotein test or a measured LDL added "to be thorough" at a screening visit falls outside the benefit unless a diagnostic reason applies. If you are paying cash for a panel instead, our lipid panel price comparison lists four sellers' prices and their fasting rules.
Medicare Advantage: federal rules (42 CFR 422.100(k)) bar deductibles, copays and coinsurance for in-network Medicare-covered preventive services, and cardiovascular screening blood tests are on that list. Diagnostic lab cost sharing is set by your plan, so check its evidence of coverage.
Who this may not fit
People with familial hypercholesterolemia, very high triglycerides, recent pancreatitis or a statin side effect being worked up are followed by their clinician on a diagnostic schedule, and the screening count does not apply to them. The 2004 regulation also defines the screening panel as one "performed after a 12-hour fasting period"; if your clinician says a nonfasting sample is fine, follow the clinician, and see our guide to nonfasting triglyceride levels for what changes in the numbers.
Chest pain or pressure, or sudden shortness of breath, is a reason to call 911, not to order a cholesterol test.
What we checked and what we did not
We read 42 CFR 410.17 on eCFR, NCD 190.23 through the CMS coverage database, the NCD's October 2026 diagnosis code list, chapter 18, section 100 and chapter 30, section 50 of CMS's claims manual, Medicare.gov's cardiovascular screening and diagnostic lab pages, the 2026 lab fee schedule and 42 CFR 422.100. We did not read any Medicare Advantage plan's lab cost sharing, and we did not test how a contractor's claim system counts dates in practice; the eligibility dates above are our reading of the rule's wording.
Every Medicare rate and coverage rule on this page was checked against the pages listed under Sources on November 16, 2026.
Frequently asked questions
How often does Medicare pay for a lipid panel?
As a screening test, once every 5 years: none is paid in the 59 months after the month of the last one. With a covered condition such as high cholesterol or diabetes, NCD 190.23 treats a yearly panel as reasonable on treatment, and allows one part of it up to six times in the first year.
Does Medicare cover a cholesterol test every year?
Only as a diagnostic test, when the order names a covered condition or treatment you are on. For people with no condition, the screening limit of once every 5 years applies.
Does a family history of heart disease let me get screened more often?
Not on its own. NCD 190.23 says testing in people without symptoms is screening "regardless of the presence of other risk factors such as family history, tobacco use, etc." Its code list does include a family history of familial hypercholesterolemia (Z83.42) and of elevated lipoprotein(a) (Z83.430), so ask whether either applies to you.
What does Medicare pay for a lipid panel in 2026?
$13.39 to the lab (code 80061), plus $9.34 if a blood draw is billed. On Original Medicare you usually pay nothing for a covered screening or diagnostic lab test.